Themis Medicare Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Low debt relative to equity (D/E 0.3x)
Concerns
- Low capital efficiency (ROCE 2.7%)
- Premium to sector peers (P/E 617x vs industry 50.2x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,758 | ₹4.2L Cr | 33.2 | 5.05 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,559 | ₹2.4L Cr | 79.8 | 15.15 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,557 | ₹1.7L Cr | 79.3 | 9.43 | 27.4 | 15.2 | 0.77 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,176 | ₹1.1L Cr | 23.1 | 4.37 | 21.2 | 21.1 | 0.38 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137 | ₹1.1L Cr | 52.8 | 12.35 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,366 | ₹1.1L Cr | 30.2 | 3.21 | 11.6 | 15.5 | 0.01 |
| LAURUSLABS Laurus Labs Limited | ₹2,182 | ₹1.1L Cr | 97.4 | 22.22 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
THEMISMED · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 67.16% | 67.15% | 67.15% | 67.15% | 67.15% | 67.15% |
| FII | 0.01% | 0.03% | 0.05% | 0.10% | 0.10% | 0.14% |
| DII | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 32.82% | 32.81% | 32.79% | 32.74% | 32.75% | 32.70% |
Latest News
All newsThemis Medicare receives credit rating update
*Themis Medicare receives credit rating update.* The company's latest credit assessment has been disclosed in a regulatory filing. No specific rating value or change is mentioned. This is a routine corporate update. 📊 *STOCKS:* $THEMIS | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CreditRating
Themis Medicare announces board meeting outcomes for Q1FY26.
*Themis Medicare announces board meeting outcomes for Q1FY26.* The company reviewed **consolidated financial results for the period ended June 30, 2026**. No major strategic moves or financial surprises were disclosed. Results are awaited for detailed performance assessment. 📊 *STOCKS:* $THEMIS | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings
Themis Medicare sees spurt in trading volume
*Themis Medicare sees spurt in trading volume* — Themis Medicare Limited witnessed a significant spike in trading volume, prompting the NSE to seek clarification to safeguard investor interests. The company has since submitted its response to the exchange. No major corporate announcement was disclosed, but the surge may indicate heightened investor speculation. 📊 *STOCKS:* THEMIS | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #volume
Themis Medicare to hold shareholder meeting on Sept 30, 2025
*Themis Medicare to hold shareholder meeting on Sept 30, 2025.* The company has announced a meeting of shareholders for September 30, 2025, as per its NSE filing. No details on agenda items were provided. Such meetings typically cover routine corporate matters. 📊 *STOCKS:* $THEMISMED | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholdersMeeting